EGFR and breast cancer: Interestingly, KEGG pathway analysis revealed that m5C methylation may be involved in the metabolic reprogramming of breast cancer cells, as well as in the regulation of key oncogenic pathways such as the ErbB, apoptosis, and DNA repair mechanisms (Supplementary Data).